Clinical conversion infrastructure
Give appropriate prospective patients a structured route into physician-led care rather than leaving your sales team to solve clinical workflow problems.
PMG works alongside DME suppliers, diagnostic laboratories, healthcare marketers, digital-health companies and other medical solution providers. Your team may create awareness, engage prospective patients or provide the healthcare solution. PMG provides the independent clinical evaluation, physician relationship, documentation and longitudinal care required to determine what is genuinely appropriate for each patient. GKIM provides the technology, integrations, workflow and governance infrastructure that enables the programme to operate at scale.

Built on more than 200,000 telehealth consultations and care delivered to more than 50,000 patients.
PMG is not a lead-generation agency, product reseller or high-volume ordering service. We provide the independent clinical layer that allows appropriate patients to progress into legitimate care.
Partners can continue to manage their existing sales, marketing, outreach and fulfilment activities. PMG assumes responsibility for the physician-led elements of the patient journey, including clinical evaluation, care planning, documentation and follow-up. This creates a clear division between commercial activity and independent medical decision-making.
Clinical decisions remain solely with PMG's licensed medical professionals. Participation in a programme does not guarantee that a product, service or diagnostic test will be ordered.
Seven stages, with responsibility named at each step. Not every patient who enters the pathway will receive a product, test or service — that decision belongs to the clinician.
The partner or its authorised acquisition channels identify potentially interested or eligible patients.
The patient enters PMG through a controlled onboarding and consent process.
A licensed PMG clinician evaluates the patient's history, needs, eligibility and existing care relationships.
PMG determines the appropriate care plan independently. This may or may not include the partner's product or service.
Medical reasoning, consent, orders, supporting documentation and care coordination are recorded within the governed clinical workflow.
Where clinically appropriate, the relevant supplier, laboratory or service provider receives the information required to fulfil its authorised role.
PMG continues the patient relationship, supports follow-up and identifies other care needs when clinically appropriate.
Give appropriate prospective patients a structured route into physician-led care rather than leaving your sales team to solve clinical workflow problems.
Replace isolated transactions with an ongoing clinical relationship that supports follow-up, adherence and future care.
Define who is responsible for acquisition, care entry, medical decision-making, documentation, fulfilment, reporting and follow-up.
Separate commercial activity from independent medical judgement and preserve a reviewable record of the patient journey.
Use configurable workflows, integrations and Medical Programmes rather than rebuilding the operating model for each new product or partner.
Open a pathway to see how the model applies to your organisation, and the topics a first discussion would cover.
DME organisations frequently have strong product expertise, sales teams, patient-acquisition capabilities and fulfilment operations. The missing component may be a consistent clinical pathway through which appropriate patients can be evaluated, documented and followed by licensed physicians.
PMG can work alongside existing DME sales and patient-acquisition teams without assuming their commercial role. PMG independently determines whether the patient requires the product, whether the relevant clinical and coverage criteria are supported, and what ongoing care is appropriate.
GKIM connects the patient, clinician, documentation, order, supplier and follow-up workflows within a governed operating system.
Product categories and workflows are considered individually according to clinical evidence, state requirements, payer rules, documentation standards and the proposed patient-acquisition model.
PMG clinicians retain complete control over patient evaluation, diagnosis, treatment and ordering.
The roles of the acquisition organisation, PMG, GKIM and fulfilment partner are documented before programme launch.
Commercial participation does not determine clinical outcomes.
Marketing, education, consent and care-entry communications must be accurate, non-coercive and consistent with the approved programme.
Patient information is shared only with authorised parties for permitted purposes and under the appropriate contractual and privacy framework.
Programmes begin with defined scope, operational controls, review points and success measures.
Every partnership progresses through the same stages, at a pace appropriate to the clinical context and organisational readiness.
Understand the organisation, product, patient-acquisition model and commercial objectives.
Review clinical relevance, patient population, payer environment, marketing approach, documentation needs and regulatory constraints.
Define responsibilities, patient handoffs, technology integration, reporting, service scope and commercial structure.
Launch a limited programme with defined patient criteria, controls, measures and review points.
Expand only after the clinical, operational and commercial model has been demonstrated.
Review outcomes, operational performance, documentation quality, patient experience and changing requirements.
We are interested in working with organisations that have a credible healthcare product, service, patient population or acquisition capability — and that recognise the need for independent physician judgement, clear operating responsibilities and long-term patient care.